329 related articles for article (PubMed ID: 18676620)
1. Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies.
Kelesidis T; Karageorgopoulos DE; Kelesidis I; Falagas ME
J Antimicrob Chemother; 2008 Nov; 62(5):895-904. PubMed ID: 18676620
[TBL] [Abstract][Full Text] [Related]
2. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
[TBL] [Abstract][Full Text] [Related]
3. Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.
Zhang R; Cai JC; Zhou HW; Nasu M; Chen GX
J Med Microbiol; 2011 Dec; 60(Pt 12):1813-1819. PubMed ID: 21835972
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of tigecycline against multidrug-resistant Enterobacteriaceae isolates from a Belgian hospital.
Naesens R; Ursi JP; Van Schaeren J; Jeurissen A
Eur J Clin Microbiol Infect Dis; 2009 Apr; 28(4):381-4. PubMed ID: 18802728
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline.
Morosini MI; García-Castillo M; Coque TM; Valverde A; Novais A; Loza E; Baquero F; Cantón R
Antimicrob Agents Chemother; 2006 Aug; 50(8):2695-9. PubMed ID: 16870760
[TBL] [Abstract][Full Text] [Related]
6. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
Garau J
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of multidrug-resistant Enterobacteriaceae clinical isolates to tigecycline.
Huang TD; Berhin C; Bogaerts P; Glupczynski Y
J Antimicrob Chemother; 2012 Nov; 67(11):2696-9. PubMed ID: 22833638
[TBL] [Abstract][Full Text] [Related]
8. Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial.
DiPersio JR; Dowzicky MJ
Int J Antimicrob Agents; 2007 May; 29(5):518-27. PubMed ID: 17376657
[TBL] [Abstract][Full Text] [Related]
9. Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline.
Chen A; Smith KP; Whitfield BA; Zucchi PC; Lasco TM; Bias TE; Kirby JE; Hirsch EB
Diagn Microbiol Infect Dis; 2017 Aug; 88(4):365-367. PubMed ID: 28535946
[TBL] [Abstract][Full Text] [Related]
10. Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Lu CT; Chuang YC; Sun W; Liu YC; Cheng YJ; Lu PL; Chen CM; Hsu GJ; Jang TN; Lee CM; Chiang PC; Shi ZY; Wang LS; Kung HC; Lin HC; Liao CH; Liu JW; Huang CH; Tsao SM; Hsueh PR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S179-83. PubMed ID: 19013351
[TBL] [Abstract][Full Text] [Related]
11. Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance.
Pournaras S; Koumaki V; Spanakis N; Gennimata V; Tsakris A
Int J Antimicrob Agents; 2016 Jul; 48(1):11-18. PubMed ID: 27256586
[TBL] [Abstract][Full Text] [Related]
12. Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance.
López-Hernández I; Alonso N; Fernández-Martínez M; Zamorano L; Rivera A; Oliver A; Conejo MC; Martínez-Martínez L; Navarro F; Pascual A
Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):499-504. PubMed ID: 27887765
[TBL] [Abstract][Full Text] [Related]
13. Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009).
Sader HS; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Feb; 69(2):223-7. PubMed ID: 21251571
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and antibiotic susceptibility pattern of CTX-M type extended-spectrum β-lactamases among clinical isolates of gram-negative bacilli in Jimma, Ethiopia.
Zeynudin A; Pritsch M; Schubert S; Messerer M; Liegl G; Hoelscher M; Belachew T; Wieser A
BMC Infect Dis; 2018 Oct; 18(1):524. PubMed ID: 30342476
[TBL] [Abstract][Full Text] [Related]
15. Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates.
Fritsche TR; Strabala PA; Sader HS; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):209-13. PubMed ID: 16105566
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
Ku YH; Chuang YC; Yu WL
J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany.
Wienke M; Pfeifer Y; Weissgerber P; Marschal M; Autenrieth IB; Gröbner S
Chemotherapy; 2012; 58(3):241-8. PubMed ID: 22832033
[TBL] [Abstract][Full Text] [Related]
18. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
Vega S; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
[TBL] [Abstract][Full Text] [Related]
20. Correlation of β-Lactamase Production and Colistin Resistance among Enterobacteriaceae Isolates from a Global Surveillance Program.
Bradford PA; Kazmierczak KM; Biedenbach DJ; Wise MG; Hackel M; Sahm DF
Antimicrob Agents Chemother; 2015 Dec; 60(3):1385-92. PubMed ID: 26666920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
